0 Mayaro virus: novel synthetic DNA vaccine provides immunity in preclinical trials
Researchers from the Wistar Institute have engineered a synthetic DNA vaccine able to provide potent immunity against the emerging Mayaro virus in mice models.
Browsing: Clinical > Vaccines
0 Micromotor formulation shows promise for oral vaccination
A biomimetic, micromotor vaccine formulation has shown promising results in immunizing against Staphylococcus aureus in mouse models.
0 Infographic: The pipeline for RSV vaccines
In this infographic we take a look at the RSV vaccines currently in the clinical pipeline and their target population from Phase I to Phase III.
0 New partnerships for antibiotic discovery and further cuts in the field: December’s industry headlines
Take a look at this month’s industry headlines including a new partnership for antibiotic development, approval for HIV drugs and authorization for a cytomegalovirus test.
0 Could an mRNA vaccine be protective against emerging tick-borne viruses?
An mRNA-based vaccine has been demonstrated to protect against Powassan virus in mice, in addition to also conferring protection against the more distantly related Langat virus.
0 Freeze-dried polio vaccine could avoid cold chain issues
Researchers have developed a freeze-dried polio vaccine that doesn’t require refrigeration and is still efficacious after rehydration.
0 Merck cuts back on rotavirus vaccine commitment to West Africa: November’s industry headlines
Positive results for zoliflodacin, EMA approval for fexinidazole and Merck cuts rotavirus commitment – take a look a the month’s industry headlines.
0 FDA grants priority review for controversial dengue vaccine, Dengvaxia
The US FDA has granted priority review for Sanofi Pasteur’s dengue vaccine, Dengvaxia®, despite its controversial past.
0 Oral cholera vaccination to be administered to 1.4 million in Zimbabwe’s capital
The WHO are amongst those aiding the Government of Zimbabwe to begin an oral cholera vaccination campaign yesterday, in efforts to immunize 1.4 million people living in high-risk regions in Harare, the capital of Zimbabwe.
0 Rotavirus vaccination has reduced infant deaths in Malawi by a third
The first population-level evidence has proved the rotavirus vaccination saves lives in low-income settings.
